'What does it say if a woman can't give birth in her… Exercise helps woman recover from partying life #MedSafetyWeek (2 to 8 November 2026): Don't ignore … Consultant doctors in England to strike next month 'We're very busy' - Inside Wales' newest hospital Can you tell ferritin levels from your face? Hospital deemed 'dangerous' and 'dreadful' online cl… Is 'ferritin face' a real thing - and can you really… The debating club that helped shape NHS architect An… The Climate Question 'What does it say if a woman can't give birth in her… Exercise helps woman recover from partying life #MedSafetyWeek (2 to 8 November 2026): Don't ignore … Consultant doctors in England to strike next month 'We're very busy' - Inside Wales' newest hospital Can you tell ferritin levels from your face? Hospital deemed 'dangerous' and 'dreadful' online cl… Is 'ferritin face' a real thing - and can you really… The debating club that helped shape NHS architect An… The Climate Question

Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health

Trial Collections

Themed entry points into Trial Radar

These collections group high-interest trial areas with nearby guidelines, Drug Science explainers and clinical briefs, so you can move from headline results to practical context without hopping across archives.

6 curated themes 2,231 total trials indexed Trial Radar plus linked clinical context

Collections

Use these to orient quickly in a topic area, then continue into the full trial archive or the relevant specialty hub.

Cardio-Renal

Cardiovascular, kidney and metabolic outcomes

A practical route into outcomes trials spanning heart failure, chronic kidney disease and diabetes-driven cardiovascular risk.

Recruiting NCT05652439

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

What is being tested: This Post Authorisation Safety Study (PASS) evaluates the incidence of cardiovascular and cerebrovascular adverse events in COPD patients…

Recruiting NCT07713719

Arterial Stiffness and Endothelial Function in Heart Failure

What is being tested: The study investigates how arterial stiffness and endothelial dysfunction contribute to poor outcomes in heart failure patients, aiming…

Phase I / Phase II Recruiting NCT06842186

A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

WVE-007 is a new injectable weight-loss drug being tested for safety and effectiveness in overweight and obese adults, with and without type…

Related Guideline Insulin efsitora alfa for treating type 2 diabetes

Drug Science HMG-CoA Reductase — Statins

Clinical Brief Inside Health

Open Trial Radar Specialty hub →

Respiratory

Airways, biologics and exacerbation prevention

Trials shaping asthma, COPD and severe airways disease management, from biologics to exacerbation reduction strategies.

Phase II Recruiting NCT07363694

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Treatment being tested: PF-07275315, a novel investigational medicine, is being evaluated for efficacy and safety in patients with moderate to severe COPD…

Phase I Recruiting NCT07822334

A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

What is being tested: RO7830698, a novel therapeutic agent, is undergoing evaluation for safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamic effects at single…

Recruiting NCT07253883

A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD

The diagnosis of either asthma or chronic obstructive pulmonary disease (COPD) is currently based on a combination of symptoms, different lung tests…

Related Guideline XVIVO Perfusion System (ex-situ machine perfusion) for assessing and reconditioning marginal lungs for transplantation: early-use assessment

Drug Science CFTR Modulation

Clinical Brief ‘Wildly unfair that my husband and I pay £4k a year for ADHD treatment’

Open Trial Radar Specialty hub →

Immunology

Inflammation, biologics and immune pathways

Immune-mediated disease research across rheumatology, dermatology and inflammatory pathways with clinically useful mechanism context.

Phase III Recruiting NCT06668181

An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Study tested bimekizumab drug levels and safety in children with inflammatory arthritis conditions.

Phase II Recruiting NCT02991469

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

SKYPS Trial Summary Sarilumab dose-finding study in children with systemic juvenile idiopathic arthritis to establish safe, effective dosing and assess safety outcomes.

Phase III Recruiting NCT07185009

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with…

Related Guideline Ex-situ machine perfusion devices to preserve deceased donor livers for transplantation

Drug Science S1P Receptor Modulation — MS/IBD

Clinical Brief NHS staff investigated over access to dead teenager’s medical records

Open Trial Radar Specialty hub →

Oncology

Checkpoint, targeted and precision oncology trials

A fast entry point into oncology trial activity, combining registry-linked studies with the supporting drug science and related clinical briefings.

Phase I Recruiting NCT07807241

A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3

What is being tested: MX006, a novel first-in-human B7-H3-targeted immunotherapy, is being evaluated in a Phase 1a/1b dose-escalation and dose-expansion study in…

Phase III Active Not Recruiting NCT06356311

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

A new cancer drug (sacituzumab tirumotecan) is being tested against standard treatment in advanced stomach cancer to see if it improves survival.

Phase III Active Not Recruiting NCT04195750

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Belzutifan compared to everolimus for advanced kidney cancer, testing if belzutifan improves survival and delays disease progression.

Related Guideline Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more lines of anti-HER2 treatment

Drug Science BRAF/MEK Pathway — Melanoma

Clinical Brief Wellbeing support demand for cancer patients grows

Open Trial Radar Specialty hub →

Neuro / Mental Health

Neurology and mental health evidence watch

Trials and linked clinical context for neurology and psychiatry where practice is moving quickly and clinicians need concise orientation.

Phase II Recruiting NCT06656416

ALTO-100 in Bipolar Disorder With Depression (BD-D)

ALTO-100 tested against placebo for treating depression in bipolar disorder patients already on mood stabilizers or antipsychotics.

Recruiting NCT07882108

Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson’s Disease

Intervention being tested: Ginger supplementation as a potential therapeutic agent to increase ghrelin levels in patients with Parkinson's disease (PD) and REM…

Recruiting NCT05632978

An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data

Study collecting blood samples and routine clinical data from people with epilepsy to identify patterns in causes, genetics, and brain characteristics.

Related Guideline Software with artificial intelligence (AI)-derived algorithms to help interpret electroencephalograms (EEGs) for suspected epilepsy: early-use assessment

Drug Science S1P Receptor Modulation — MS/IBD

Clinical Brief Fitness became an addiction that left me anxious and sleep deprived

Open Trial Radar Specialty hub →

Infectious Disease

Infection, antimicrobial and outbreak-linked research

Current infectious disease trials with the nearby clinical updates and guidance needed to place them in real-world practice.

Phase I Active Not Recruiting NCT07053384

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

Trial testing VH3810109 alone or with fostemsavir to shrink and reduce HIV reservoir activity in treatment-naive and treatment-experienced patients.

Phase III Recruiting NCT07650916

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

What is being tested: Cabotegravir ultra long-acting (CAB ULA) plus rilpivirine ultra-acting (RPV ULA) injections are being compared against standard long-acting formulations…

Phase II / Phase III Recruiting NCT07214311

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

PLG0206 tested as wound irrigation during knee implant infection surgery to prevent reinfection and improve outcomes.

Related Guideline Transvenous embolisation for spontaneous intracranial hypotension caused by a cerebrospinal fluid–venous fistula

Drug Science IL-6 Signalling

Clinical Brief ‘Betrayed by my body’: The taboo health issue women are talking about on social media

Open Trial Radar Specialty hub →

Stay Updated

Follow Trial Radar and research invitations

Choose trial, safety, guideline and research updates by specialty so new evidence lands in the right place.

Set Research Preferences →